Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects

PURPOSE: Pioglitazone, an antihyperglycemic drug, is widely used in diabetes mellitus patients with insulin resistance. Although pioglitazone is known to have a potential link to bladder cancer (BC), there have been contradictory results. This present study is designed to understand the regulatory m...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Muhammad, Kim, Minhyung, Yeon, Austin, Jin, Peng, Kim, Woong-Ki, You, Sungyong, Kim, Jayoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136443/
https://www.ncbi.nlm.nih.gov/pubmed/32252184
http://dx.doi.org/10.5213/inj.1938186.093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136443/
https://www.ncbi.nlm.nih.gov/pubmed/32252184
http://dx.doi.org/10.5213/inj.1938186.093

Ejemplares similares